Trials / Conditions / Ulcerative Colitis, Active Severe
Ulcerative Colitis, Active Severe
4 registered clinical trials studyying Ulcerative Colitis, Active Severe — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis NCT07415044 | Eli Lilly and Company | Phase 2 |
| Completed | TD-1473 for Active Ulcerative Colitis (UC) NCT02818686 | Theravance Biopharma | Phase 1 |
| Terminated | Evaluation of Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of Bertilimumab in Patients With Active Mo NCT01671956 | Alexion Pharmaceuticals, Inc. | Phase 2 |
| Completed | Manipulating the Microbiome in IBD by Antibiotics and FMT NCT02033408 | Shaare Zedek Medical Center | N/A |